Author/Creator: Sun, Lillian - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Sun, Lillian

1. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies. Issue 1 (21st June 2018)

Authors:: Friedman, Jay; Morisada, Megan; Sun, Lillian; Moore, Ellen C.; Padget, Michelle; Hodge, James W.; Schlom, Jeffrey; Gameiro, Sofia R.; Allen, Clint T.
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 6:Issue 1(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms. (3rd July 2018)

Authors:: Moore, Ellen C.; Sun, Lillian; Clavijo, Paul E.; Friedman, Jay; Harford, Joe B.; Saleh, Anthony D.; Van Waes, Carter; Chang, Esther H.; Allen, Clint T.
Journal:: Oncoimmunology
Issue:: Volume 7:Number 7(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation. (4th March 2018)

Authors:: Morisada, Megan; Clavijo, Paul E.; Moore, Ellen; Sun, Lillian; Chamberlin, Michael; Van Waes, Carter; Hodge, James W.; Mitchell, James B.; Friedman, Jay; Allen, Clint T.
Journal:: Oncoimmunology
Issue:: Volume 7:Number 3(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Preliminary Analysis of Within-Sample Co-methylation Patterns in Normal and Cancerous Breast Samples. (October 2019)

Authors:: Sun, Lillian; Namboodiri, Surya; Chen, Emily; Sun, Shuying
Journal:: Cancer informatics
Issue:: Volume 18(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series. Issue 1 (16th May 2018)

Authors:: Sun, Lillian; Funchain, Pauline; Song, Jung Min; Rayman, Patricia; Tannenbaum, Charles; Ko, Jennifer; Mcnamara, Michael; Marcela Diaz-Montero, C.; Gastman, Brian
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 6:Issue 1(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy. (3rd October 2018)

Authors:: Sun, Lillian; Moore, Ellen; Berman, Rose; Clavijo, Paul E.; Saleh, Anthony; Chen, Zhong; Van Waes, Carter; Davies, John; Friedman, Jay; Allen, Clint T.
Journal:: Oncoimmunology
Issue:: Volume 7:Number 10(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗